Pegcetacoplan inhibits C3 activation by binding to C3 and its activation fragment C3b, thereby reducing C3 glomerular fragment deposition in patients with C3G and primary IC-MPGN.

HHS Sec. Robert F. Kennedy, Jr. and Sen. Markwayne Mullin (R-OK), along with FDA Commissioner Dr. Marty Makary, announce new ...

The FDA plans to add the compound to Schedule I under the Controlled Substances Act, meaning the product has a high misuse ...

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the ...

Federal officials said a psychoactive ingredient in kratom had been refined and added to supplements that could quickly ...

The Food and Drug Administration is considering adding warning labels to antidepressants for women who are pregnant, despite ...

The Food and Drug Administration on Tuesday recommended classifying 7-OH, a compound with opioid-like effects found in ...

Federal regulators have been scrutinizing kratom for about a decade after reports of addiction, injury and overdose ...

The Food and Drug Administration has expanded a recall involving ready-to-eat items made with tuna salad. The recall involves ...

Numerous recalls have been initiated in 2025 due to the potential for damaged products, foodborne illness, contamination and undeclared food allergens.

Kratom advocates in Ohio praise its benefits in its pure form; however, many have called for a ban on altered, concentrated, ...

Dangerous products are marketed as “kratom extract” or “enhanced kratom” and often disguised as candies, gummies and even ice ...